Alicia W Gilsenan

10PUBLICATIONS
31CO-AUTHORS
PharmacogenomicsEpidemiological modellingPredictive and prognostic markersForensic epidemiologyDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Dec 30, 2022
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting.

Heather E Danysh, Catherine B Johannes, Daniel C Beachler

|Dec 17, 2022
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting.

Catherine B Johannes, Daniel C Beachler, J Bradley Layton

|Sep 16, 2022
Teriparatide and Osteosarcoma Risk: History, Science, Elimination of Boxed Warning, and Other Label Updates.

John H Krege, Alicia W Gilsenan, John L Komacko

|Aug 26, 2022
Risk of Major Cardiovascular and Cerebrovascular Events in Users of Lisdexamfetamine and Other Medications for Attention-Deficit/Hyperactivity Disorder in Denmark and Sweden: A Population-Based Cohort Study.

Joan Forns, Elena Dudukina, David Hägg

|Nov 05, 2020
Long-term cancer surveillance: results from the Forteo Patient Registry Surveillance Study.

A Gilsenan, D Harris, M Reynolds

|Oct 22, 2020
Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom.

Alejandro Arana, Andrea V Margulis, Cristina Varas-Lorenzo

Pageof 2

Frequent Collaborators

3 joint publications

Alejandro Arana

2 joint publications

Brian Calingaert

2 joint publications

Ryan Ziemiecki

2 joint publications

J Bradley Layton